To direct the Attorney General to amend certain regulations so that practitioners may administer not more than 3 days' medication to a person at one time when administering narcotic drugs for the purpose of relieving acute withdrawal symptoms.
The bill’s titles are written by its sponsor.
Sponsor and status
116th Congress (2019–2021)
This bill was introduced in a previous session of Congress and was passed by the House on November 17, 2020 but was never passed by the Senate.
Although this bill was not enacted, its provisions could have become law by being included in another bill. It is common for legislative text to be introduced concurrently in multiple bills (called companion bills), re-introduced in subsequent sessions of Congress in new bills, or added to larger bills (sometimes called omnibus bills).
1 Cosponsor (1 Republican)
Position statements
What legislators are saying
“Dr. Ruizs Bill to Help Address Opioid Crisis Signed into Law”
—
Rep. Raul Ruiz [D-CA25]
(Sponsor)
on Dec 14, 2020
“Homeland Preparedness News: U.S. House approves 10 healthcare bills, including several targeting opioid crisis”
—
Rep. Michael Burgess [R-TX26]
on Nov 18, 2020
“The Opioid Crisis: The Next Step in the Fight”
—
Rep. Susan Brooks [R-IN5, 2013-2020]
on Nov 25, 2019
More statements at ProPublica Represent...
What stakeholders are saying
History
|
May 10, 2018
|
|
Earlier Version —
Introduced
This activity took place on a related bill, H.R. 5770 (115th). |
|
Apr 10, 2019
|
|
Introduced
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber. |
|
Mar 3, 2020
|
|
Considered by Health
A committee held a hearing or business meeting about the bill.
|
|
Sep 9, 2020
|
|
Ordered Reported
A committee has voted to issue a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee. |
|
Nov 13, 2020
|
|
Text Published
Updated bill text was published as of Preprint (Suspension). |
|
Nov 16, 2020
|
|
Reported by House Committee on Energy and Commerce
A committee issued a report on the bill, which often provides helpful explanatory background on the issue addressed by the bill and the bill's intentions. |
|
Nov 17, 2020
|
|
Passed House (Senate next)
The bill was passed in a vote in the House. It goes to the Senate next. The vote was by voice vote so no record of individual votes was made. |
H.R. 2281 (116th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
Bills numbers restart every two years. That means there are other bills with the number H.R. 2281. This is the one from the 116th Congress.
This bill was introduced in the 116th Congress, which met from Jan 3, 2019 to Jan 3, 2021. Legislation not passed by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
“H.R. 2281 — 116th Congress: Easy MAT for Opioid Addiction Act.” www.GovTrack.us. 2019. March 29, 2023 <https://www.govtrack.us/congress/bills/116/hr2281>
- show another citation format:
- APA
- Blue Book
- Wikipedia Template
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.
